113 related articles for article (PubMed ID: 37706561)
1. miR-19a may function as a biomarker of oral squamous cell carcinoma (OSCC) by regulating the signaling pathway of miR-19a/GRK6/GPCRs/PKC in a Chinese population.
Chen J; Wang L; Ma D; Zhang H; Fan J; Gao H; Xia X; Wu W; Shi Y
J Oral Pathol Med; 2023 Nov; 52(10):971-979. PubMed ID: 37706561
[TBL] [Abstract][Full Text] [Related]
2. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
[TBL] [Abstract][Full Text] [Related]
3. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
4. MicroRNA-382-5p Promotes Oral Squamous Cell Carcinoma Development and Progression by Negatively Regulating PTEN Expression.
Xu X; Jin B; Cai L; Zhang Z; Ying Y; Luo J
J Oral Maxillofac Surg; 2022 Dec; 80(12):2015-2023. PubMed ID: 36162436
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
[TBL] [Abstract][Full Text] [Related]
6. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
7. Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI.
Wei Z; Lyu B; Hou D; Liu X
J Invest Surg; 2021 Aug; 34(8):834-841. PubMed ID: 31851859
[TBL] [Abstract][Full Text] [Related]
8. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
9. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.
Jun W; Shaobo O; Xianhua Z; Siyu Z; Mingyang C; Xin F; Ying C; Lan L
Sci Rep; 2021 Oct; 11(1):20561. PubMed ID: 34663837
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
[TBL] [Abstract][Full Text] [Related]
13. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
[TBL] [Abstract][Full Text] [Related]
14. Downregulated microRNA-149-3p triggers malignant development and predicts worse prognosis in oral squamous cell carcinoma.
Shen Q; Xiong P; Yang D; Chen L
Arch Oral Biol; 2022 Feb; 134():105336. PubMed ID: 34891100
[TBL] [Abstract][Full Text] [Related]
15. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
[TBL] [Abstract][Full Text] [Related]
16. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
Zhang XJ; Jin Y; Song JL; Deng F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
[TBL] [Abstract][Full Text] [Related]
17. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells.
Sun H; Feng X
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378714
[TBL] [Abstract][Full Text] [Related]
20. MiR-590-5p regulates cell proliferation, apoptosis, migration and invasion in oral squamous cell carcinoma by targeting RECK.
Bao WW; Shi YL; Ma Y; Qu XH; Pang GM; Yang L
Histol Histopathol; 2021 Mar; 36(3):355-365. PubMed ID: 33447989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]